Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/04/2022* -- Results Q4 2022 -- 2.74 --
11/04/2022* 08:00 EST Earnings Call Q4 2022 -- -- --
08/04/2022 08:00 EST Earnings Call Q3 2022 -- -- --
08/04/2022 -- Results Q3 2022 2.66 2.50 6.45%
05/05/2022 -- Results Q2 2022 3.18 2.95 7.88%
05/05/2022 08:00 EST Earnings Call Q2 2022 -- -- --
02/03/2022 -- Results Q1 2022 3.64 2.85 27.52%
02/03/2022 08:00 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/04/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since -5.84%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
URL http://www.bd.com
Investor Relations URL https://investors.bd.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Large Cap/Blend
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 08, 2022

Dividends

Dividend Per Share (TTM) 3.44
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.9998
Yield to Sector 0.7958
Yield to Industry 1.678
Last Dividend Amt. 0.87
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 08, 2022
Yield (TTM) 1.47%
Forward Yield 1.47%
Payout Ratio 60.99%
Cash Payout Ratio 73.06%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
12.64%
9.23%
31.23%
6.62%
22.20%
-6.75%
1.88%
-4.82%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.50%
1.89%
-12.32%
52.00%
29.04%
22.10%
28.00%
30.54%
-25.88%
137.2%
24.81%
66.32%
73.44%
-47.52%
90.05%
10.79%
-26.49%
--
--
--
--
--
136.2%
71.93%
60.86%
0.01%
30.68%
30.84%
2.43%
35.33%
18.15%
10.22%
-18.54%
As of October 04, 2022.

Profile

Edit
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
URL http://www.bd.com
Investor Relations URL https://investors.bd.com/
HQ State/Province New Jersey
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Large Cap/Blend
Next Earnings Release Nov. 04, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 08, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
JENRX 422.30M USD 4.34%
IHI 247.92M USD 4.22%
PRBLX 1.043B USD 4.07%
PAVLX 1.224B USD 3.95%
FRDRX 605.93M USD 2.49%
PACLX 909.54M USD 2.00%
THQ 16.97M USD 1.91%
RRFDX 295.84M USD 1.74%
ZLU.TO 20.26M USD 1.40%
IYH 39.97M USD 1.35%
VHT 244.30M USD 1.31%
FHLC 34.21M USD 1.21%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BDX Tweets